¼¼°èÀÇ ÀÇ·á¿ë ÄݵåüÀÎ º¸°ü Àåºñ ½ÃÀå : Á¦Ç° Á¾·ùº°, ¿Âµµ ¹üÀ§º°, ±â¼úº°, ¿ëµµº°, ÃÖÁ¾»ç¿ëÀÚº°, ±¹°¡º°, Áö¿ªº° - »ê¾÷ ºÐ¼®, ½ÃÀå ±Ô¸ð, ½ÃÀå Á¡À¯À², ¿¹Ãø(2025-2032³â)
Medical Cold Chain Storage Equipment Market, By Product Type, By Temperature Range, By Technology, By Application, By End User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
»óǰÄÚµå : 1684276
¸®¼­Ä¡»ç : AnalystView Market Insights
¹ßÇàÀÏ : 2025³â 03¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 359 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 3,250 £Ü 4,518,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠺Ұ¡´ÉÇϸç, ÅØ½ºÆ®ÀÇ Copy&Pasteµµ ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 4,650 £Ü 6,464,000
PDF (5 User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 5,650 £Ü 7,855,000
PDF & Excel (Enterprise User License) help
PDF & Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ ³» ¸ðµç »ç¿ëÀÚ°¡ »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy&Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

º¸°í¼­ ÇÏÀ̶óÀÌÆ®

ÀÇ·á¿ë ÄݵåüÀÎ º¸°ü Àåºñ ½ÃÀå ±Ô¸ð´Â 2024³â 31¾ï 2,345¸¸ ´Þ·¯·Î 2025³âºÎÅÍ 2032³â±îÁö CAGR 5.5%·Î È®´ëµÉ Àü¸ÁÀÔ´Ï´Ù.

ÀÇ·á¿ë ÄݵåüÀÎ ½ºÅ丮Áö Àåºñ ½ÃÀå ¿ªÇÐ

¹é½Å°ú »ý¹°ÇÐÀû Á¦Á¦¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡°¡ ½ÃÀå È®´ë¸¦ ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. COVID-19, µ¶°¨, °£¿°, HPV µî °¨¿°¼º ÁúȯÀÇ ¹ßº´·ü Áõ°¡·Î ÀÎÇØ ¹é½Å ¹× »ý¹°ÇÐÀû Á¦Á¦¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϸ鼭 ¹é½Å »ý»ê ¹× À¯ÅëÀÌ ÃËÁøµÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. À¯´Ï¼¼ÇÁ µ¥ÀÌÅÍ¿¡ µû¸£¸é, ¿¹¹æÁ¢Á¾Àº °¡Àå ºñ¿ë È¿À²ÀûÀÎ °øÁߺ¸°Ç ´ëÃ¥ Áß ÇϳªÀ̸ç, ¿¬°£ ¾à 440¸¸ ¸íÀÇ »ç¸ÁÀ» ¿¹¹æÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¸ÂÃãÇü ÀÇ·á, ¼¼Æ÷ ¹× À¯ÀüÀÚ Ä¡·á, Àç»ý ÀÇÇÐÀÇ ¹ßÀüÀ¸·Î ÀÎÇØ ¿µÇÏ 150¡É ÀÌÇÏ¿¡¼­ ÀÛµ¿ÇÏ´Â Àú¿Â ³Ãµ¿°íÀÇ Çʿ伺ÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ±×·³¿¡µµ ºÒ±¸Çϰí, ÄݵåüÀÎ ½ºÅ丮ÁöÀÇ ±â¼ú Çõ½ÅÀº ½ÃÀå ¼ºÀåÀÇ ±âȸ¸¦ °¡Á®¿Ã ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ½ÅÈï±¹ ½ÃÀå¿¡¼­´Â ÀÎÇÁ¶ó°¡ ºÎÁ·ÇÏ¿© ½ÃÀå °³Ã´¿¡ °É¸²µ¹ÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù.

ÀÇ·á¿ë ÄݵåüÀÎ ½ºÅ丮Áö Àåºñ ½ÃÀå : ÁÖ¿ä ÀλçÀÌÆ®

¸®¼­Ä¡ ¾Ö³Î¸®½ºÆ®ÀÇ ºÐ¼®¿¡ µû¸£¸é, ¼¼°è ½ÃÀåÀº ¿¹Ãø ±â°£(2025-2032³â) µ¿¾È ¾à 5.5%ÀÇ CAGR·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

Á¦Ç° À¯Çüº°·Î´Â ³Ãµ¿°í°¡ 2024³â °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¾ú½À´Ï´Ù.

ÃÖÁ¾»ç¿ëÀÚº°·Î´Â Á¦¾àȸ»ç°¡ 2024³â ÁÖ¿ä ÃÖÁ¾»ç¿ëÀÚÀÔ´Ï´Ù.

Áö¿ªº°·Î´Â ºÏ¹Ì°¡ 2024³â ¼öÀÍÀ» âÃâÇÏ´Â ÁÖ¿ä ½ÃÀåÀÔ´Ï´Ù.

ÀÇ·á¿ë ÄݵåüÀÎ ½ºÅ丮Áö Àåºñ ½ÃÀå : ¼¼ºÐÈ­ ºÐ¼®

ÀÇ·á¿ë ÄݵåüÀÎ ½ºÅ丮Áö Àåºñ ¼¼°è ½ÃÀåÀº Á¦Ç° À¯Çü, ¿Âµµ ¹üÀ§, ±â¼ú, ¿ëµµ, ÃÖÁ¾»ç¿ëÀÚ, Áö¿ª¿¡ µû¶ó ¼¼ºÐÈ­µË´Ï´Ù.

½ÃÀåÀº Á¦Ç° À¯Çü¿¡ µû¶ó ³ÃÀå°í, ³Ãµ¿°í, Àú¿Â ÀúÀå ½Ã½ºÅÛ, ÄÝµå ·ë, ±âŸ(¾ÆÀ̽º ¶óÀÎ ³ÃÀå°í, ž翭 Á÷Á¢ ±¸µ¿ ³ÃÀå°í µî) µî 4°¡Áö·Î ºÐ·ùµË´Ï´Ù. ½ÃÀå ¼ºÀåÀ» ÁÖµµÇÏ´Â °ÍÀº ³Ãµ¿°íÀÔ´Ï´Ù. ÀÇ·á¿ë ÄݵåüÀÎ º¸°ü Àåºñ ½ÃÀåÀÇ ¼ºÀåÀ» ÁÖµµÇÏ´Â °ÍÀº ÁÖ·Î ¿Âµµ¿¡ ¹Î°¨ÇÑ ÀǾàǰ, »ý¹°ÇÐÀû Á¦Á¦, ¹é½Å¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡·Î ÀÎÇØ ³Ãµ¿°í°¡ ¾ÐµµÀûÀÎ Á¡À¯À²À» Â÷ÁöÇϰí ÀÖ½À´Ï´Ù. ÃÊÀú¿Â(ULT) ³Ãµ¿°í ¹× ±ØÀú¿Â ÀúÀå ¼Ö·ç¼ÇÀÇ Ã¤ÅÃÀÌ Áõ°¡Çϰí ÀÖ´Â °ÍÀÌ ½ÃÀå È®´ë¿¡ Å©°Ô ±â¿©Çϰí ÀÖ½À´Ï´Ù. ½á¸ðÇǼÅ, PHC Ȧµù½º, ÇÏÀ̾ó ¹ÙÀÌ¿À¸ÞµðÄÃ, Å©¶óÀÌ¿ÀÆ÷Æ®´Â ÃÊÀú¿Â ¹× ±ØÀú¿Â ³Ãµ¿±âÀÇ ±â¼ú Çõ½ÅÀ¸·Î ½ÃÀåÀ» ¼±µµÇϰí ÀÖ½À´Ï´Ù. ÀÇ·á¿ë ÄݵåüÀÎ ½ºÅ丮ÁöÀÇ ¹Ì·¡´Â ÷´Ü ³Ãµ¿°í ¼Ö·ç¼Ç¿¡ Å©°Ô ÀÇÁ¸ÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.

ÀÇ·á¿ë ÄݵåüÀÎ ½ÃÀåÀº ¿Âµµ ¹üÀ§¿¡ µû¶ó 2¡É¿¡¼­ 8¡É, -20¡É¿¡¼­ -40¡É, -40¡É¿¡¼­ -80 ¡É, -80¡É ÀÌÇÏÀÇ 4 °¡Áö ¹üÁÖ·Î ºÐ·ùµË´Ï´Ù. ÀÇ·á¿ë ÄݵåüÀÎ º¸°ü Àåºñ ½ÃÀåÀº ÀÇ·á¿ë º¸°üÀÇ ´Ù¾çÇÑ ¿ä±¸ »çÇ×À» ÃæÁ·½Ã۱â À§ÇØ ¿Âµµ ¹üÀ§¿¡ µû¶ó ºÐ·ùµË´Ï´Ù. °¢ ¿Âµµ ¹üÀ§´Â ƯÁ¤ ¿ëµµ¿¡ »ç¿ëµÇ¸ç, ÇØ´ç ºÎ¹®¿¡¼­ °æÀïÇÏ´Â ÁÖ¿ä ±â¾÷µéÀÌ Á¸ÀçÇÕ´Ï´Ù. ÀÇ·á¿ë ÄݵåüÀÎ º¸°ü Àåºñ ½ÃÀåÀº ¿Âµµ ¹üÀ§º°·Î ºÐ·ùµÇ¸ç, Thermo Fisher, PHC Holdings, Haier BiomedicalÀÌ ¿©·¯ Ä«Å×°í¸®¿¡¼­ ¼±µÎ¸¦ ´Þ¸®°í ÀÖ½À´Ï´Ù. ¹é½Å º¸°ü(2¡É-8¡É)°ú mRNA ¹é½Å º¸°ü(-80¡É ÀÌÇÏ)ÀÌ ¼ö¿ä¸¦ ÁÖµµÇϰí ÀÖÀ¸¸ç, »ý¹°ÇÐÀû Á¦Á¦ ¹× Àç»ýÀÇ·á°¡ ±ØÀú¿Â º¸°üÀÇ ±â¼ú Çõ½ÅÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù.

½ÃÀåÀº ±â¼úº°·Î ¾ÐÃà±â½Ä ½Ã½ºÅÛ, Èí¼ö½Ä ½Ã½ºÅÛ, ¿­Àü½Ä ½Ã½ºÅÛ µî ¼¼ °¡Áö ¹üÁÖ·Î ³ª´¹´Ï´Ù. ±â¼úº°·Î ºÐ·ùµÈ ÀÇ·á¿ë ÄݵåüÀÎ º¸°ü Àåºñ ½ÃÀåÀº ¹é½Å, ÀǾàǰ, »ý¹°ÇÐÀû Á¦Á¦ÀÇ º¸Á¸¿¡ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. ÀÌ ½ÃÀåÀº ¾ÐÃà±â½Ä ½Ã½ºÅÛ, Èí¼ö½Ä ½Ã½ºÅÛ, ¿­Àü½Ä ½Ã½ºÅÛÀ¸·Î ºÐ·ùµÇ¸ç, °¢ ½Ã½ºÅÛÀº ÀÀ¿ë ¿ä±¸»çÇ׿¡ µû¶ó ¶Ñ·ÇÇÑ ÀåÁ¡À» °¡Áö°í ÀÖ½À´Ï´Ù.

½ÃÀåÀº ¿ëµµ¿¡ µû¶ó ¹é½Å º¸°ü, Ç÷¾× ¹× Ç÷¾×Á¦Á¦ º¸°ü, »ý¹°ÇÐÀû »ùÇà º¸°ü, ¾àǰ ¹× ÀǾàǰ º¸°ü, ±âŸ(Àå±â º¸°ü, ¼¼Æ÷¹è¾ç¾× µî)ÀÇ 4°¡Áö ¹üÁÖ·Î ³ª´¹´Ï´Ù. ¿ëµµº°·Î ºÐ·ùµÈ ÀÇ·á¿ë ÄݵåüÀÎ º¸°ü Àåºñ ½ÃÀåÀº ¹é½Å, Ç÷¾×Á¦Á¦, »ý¹°ÇÐÀû »ùÇÃ, ÀǾàǰ µî ¿Âµµ¿¡ ¹Î°¨ÇÑ ÀÇ·áÁ¦Ç°ÀÇ º¸°ü¿¡ ÇʼöÀûÀÔ´Ï´Ù. °¢ ¿ëµµ´Â Á¦Ç°ÀÇ ¹«°á¼º°ú À¯È¿¼ºÀ» º¸ÀåÇϱâ À§ÇØ Æ¯Á¤ º¸°ü Á¶°ÇÀÌ ¿ä±¸µË´Ï´Ù.

½ÃÀåÀº ÃÖÁ¾»ç¿ëÀÚº°·Î º´¿ø ¹× Ŭ¸®´Ð, Á¦¾àȸ»ç, ¿¬±¸±â°ü, Ç÷¾×ÀºÇà, ¾à±¹, ±âŸ(Çмú±â°ü, Áø´Ü¼¾ÅÍ µî) µî 5°¡Áö·Î ºÐ·ùµË´Ï´Ù. Á¦¾àȸ»ç°¡ ½ÃÀå ¼ºÀåÀ» ÁÖµµÇÏ´Â ÀÇ·á¿ë ÄݵåüÀÎ º¸°ü Àåºñ ½ÃÀåÀº Á¦¾àȸ»ç¿¡°Ô ¿Âµµ¿¡ ¹Î°¨ÇÑ ÀǾàǰ, ¹é½Å, »ý¹°ÇÐÀû Á¦Á¦ÀÇ ¾ÈÁ¤¼º°ú À¯È¿¼ºÀ» º¸ÀåÇϱâ À§ÇØ ÇʼöÀûÀÔ´Ï´Ù. Á¦¾à»çµéÀº ±ÔÁ¦ ±âÁØÀ» ÁؼöÇÏ°í º¸°ü ¹× À¯Åë ÁßÀÎ Á¦Ç°ÀÇ ¹«°á¼ºÀ» À¯ÁöÇϱâ À§ÇØ Ã·´Ü ÄÝµå ½ºÅ丮Áö ±â¼ú¿¡ ÀÇÁ¸Çϰí ÀÖ½À´Ï´Ù.

ÀÇ·á¿ë ÄݵåüÀÎ ½ºÅ丮Áö Àåºñ ½ÃÀå : Áö¿ªº° ºÐ¼®

ºÏ¹Ì´Â ÁÖ·Î ¹ÙÀÌ¿ÀÀǾàǰ ºÎ¹®ÀÇ ¼ºÀåÀ¸·Î ÀÎÇØ ½ÃÀå È®´ëÀÇ ÃÖÀü¼±¿¡ ÀÖ½À´Ï´Ù. ¹Ì±¹°ú ij³ª´Ù¿¡´Â »ý¹°ÇÐÀû Á¦Á¦, ´ÜŬ·ÐÇ×ü, mRNA ¹é½Å, À¯ÀüÀÚ Ä¡·á¿¡ ¸¹Àº ÅõÀÚ¸¦ Çϰí ÀÖ´Â Àú¸íÇÑ ¹ÙÀÌ¿À Á¦¾à ±â¾÷ÀÌ ÀÖÀ¸¸ç, ¸ðµÎ ¾ö°ÝÇÑ ¿Âµµ °ü¸®°¡ ÇÊ¿äÇÕ´Ï´Ù. Á¦¾à¿¬±¸Á¦Á¶¾÷Çùȸ(PhRMA)ÀÇ º¸°í¼­¿¡ µû¸£¸é, ¹Ì±¹ ¹ÙÀÌ¿ÀÁ¦¾à±â¾÷µéÀº 2023³â ¾à 960¾ï ´Þ·¯¸¦ ¿¬±¸°³¹ß¿¡ ÅõÀÚÇÒ °ÍÀ¸·Î ¿¹»óÇϰí ÀÖ½À´Ï´Ù. ¾Æ½Ã¾ÆÅÂÆò¾çÀº ¹é½Å Á¦Á¶ÀÇ ¹ßÀü°ú ÀÇ·á ¼­ºñ½º È®´ë¿¡ ÈûÀÔ¾î ºü¸£°Ô ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. ¹Ý¸é, À¯·´Àº ÷´Ü ¹ÙÀÌ¿À±â¼ú°ú Áö¼Ó°¡´É¼º¿¡ ´ëÇÑ ³ë·Â¿¡ ÈûÀÔ¾î °ßÁ¶ÇÑ ¼ºÀå¼¼¸¦ À̾°í ÀÖ½À´Ï´Ù.

ÀÇ·á¿ë ÄݵåüÀÎ ½ºÅ丮Áö Àåºñ ½ÃÀå : °æÀï »óȲ

ÀÇ·á¿ë ÄݵåüÀÎ º¸°ü Àåºñ ½ÃÀåÀº ±â¼ú ¹ßÀü°ú ¿Âµµ º¯È­¿¡ ¹Î°¨ÇÑ ÀǾàǰ¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡·Î ÀÎÇØ Å©°Ô ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. Áö¼Ó°¡´ÉÇϰí È¿°úÀûÀÎ ÄÝµå ½ºÅ丮Áö ¼Ö·ç¼ÇÀ» ¿ì¼±½ÃÇÏ´Â ±â¾÷µéÀº ÀÌ·¯ÇÑ ¿ªµ¿ÀûÀΠȯ°æ¿¡¼­ °æÀï ¿ìÀ§¸¦ È®º¸ÇÒ ¼ö ÀÖÀ» °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. Thermo FisherÀÇ Ã·´Ü ³Ãµ¿ ±â¼ú Àü¹® ±â¾÷ Àμö¸¦ ÅëÇØ ´ëÇ¥ÀûÀ¸·Î º¼ ¼ö ÀÖµíÀÌ, ´ë±â¾÷µéÀº Á¦Ç° ¶óÀξ÷À» È®ÀåÇϱâ À§ÇØ Áß¼Ò±â¾÷À» ÀμöÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ±â¾÷µéÀº ¼¼°è Áö¼Ó°¡´É¼º ¸ñÇ¥¿¡ ºÎÇÕÇϱâ À§ÇØ Ä£È¯°æ ³Ã¸Å »ç¿ë°ú ¿¡³ÊÁö È¿À²ÀÌ ³ôÀº ³Ã°¢ ½Ã½ºÅÛ¿¡ ÁýÁßÇϰí ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÀÇ·á¿ë ÄݵåüÀÎ º¸°ü Àåºñ ½ÃÀå °³¿ä

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ÀÇ·á¿ë ÄݵåüÀÎ º¸°ü ÀåºñÀÇ ÁÖ¿ä ½ÃÀå µ¿Çâ

Á¦4Àå ÀÇ·á¿ë ÄݵåüÀÎ º¸°ü Àåºñ ½ÃÀå : »ê¾÷ ºÐ¼®

Á¦5Àå ÀÇ·á¿ë ÄݵåüÀÎ º¸°ü Àåºñ ½ÃÀå : ³ô¾ÆÁö´Â ÁöÁ¤ÇÐÀû ±äÀåÀÇ ¿µÇâ

Á¦6Àå ÀÇ·á¿ë ÄݵåüÀÎ º¸°ü Àåºñ ½ÃÀå »óȲ

Á¦7Àå ÀÇ·á¿ë ÄݵåüÀÎ º¸°ü Àåºñ ½ÃÀå : Á¦Ç° Á¾·ùº°

Á¦8Àå ÀÇ·á¿ë ÄݵåüÀÎ º¸°ü Àåºñ ½ÃÀå : ¿Âµµ ¹üÀ§º°

Á¦9Àå ÀÇ·á¿ë ÄݵåüÀÎ º¸°ü Àåºñ ½ÃÀå : ±â¼úº°

Á¦10Àå ÀÇ·á¿ë ÄݵåüÀÎ º¸°ü Àåºñ ½ÃÀå : ¿ëµµº°

Á¦11Àå ÀÇ·á¿ë ÄݵåüÀÎ º¸°ü Àåºñ ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

Á¦12Àå ÀÇ·á¿ë ÄݵåüÀÎ º¸°ü Àåºñ ½ÃÀå : Áö¿ªº°

Á¦13Àå ÁÖ¿ä º¥´õ ºÐ¼® : ÀÇ·á¿ë ÄݵåüÀÎ º¸°ü Àåºñ ¾÷°è

Á¦14Àå AnalystViewÀÇ Àü¹æÀ§Àû ºÐ¼®

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

REPORT HIGHLIGHT

Medical Cold Chain Storage Equipment Market size was valued at US$ 3,123.45 Million in 2024, expanding at a CAGR of 5.5% from 2025 to 2032.

Medical Cold Chain Storage Equipment encompasses specialized refrigeration and temperature-regulated storage systems designed to maintain the potency, safety, and efficacy of temperature-sensitive medical products, including vaccines, blood, pharmaceuticals, biologics, and laboratory specimens. These systems are crucial in ensuring that medical supplies are kept within precise temperature ranges throughout the entire process from production to distribution and eventual use. In 2023, UNICEF invested USD105.9 million in cold chain equipment and services. They collaborate closely with partners and governments to guarantee the effective and efficient operation of the cold chain in every country where we provide vaccines to children.

Medical Cold Chain Storage Equipment Market- Market Dynamics

The rise in demand for vaccines and biologics is expected to propel market expansion. The growing incidence of infectious diseases, including COVID-19, influenza, hepatitis, and HPV, has expedited the production and distribution of vaccines. Immunization stands as one of the most cost-effective public health measures, preventing an estimated 4.4 million deaths annually, according to UNICEF data. Furthermore, advancements in personalized medicine, cell and gene therapies, and regenerative medicine have heightened the requirement for cryogenic freezers operating at -150°C and lower. Nevertheless, technological innovations in cold chain storage may present opportunities for market growth. Additionally, inadequate infrastructure in developing regions could hinder market progress.

Medical Cold Chain Storage Equipment Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 5.5% over the forecast period (2025-2032)

Based on product type segmentation, Freezers were predicted to show maximum market share in the year 2024

Based on end-user segmentation, Pharmaceutical companies were the leading end users in 2024

Based on region, North America was the leading revenue generator in 2024

Medical Cold Chain Storage Equipment Market- Segmentation Analysis:

The Global Medical Cold Chain Storage Equipment Market is segmented based on Product Type, Temperature Range, Technology, Application, End User, and Region.

The market is divided into four categories based on product type: Refrigerators, Freezers, Cryogenic storage systems, Cold rooms, and others (ice-lined refrigerators, solar direct drive refrigerators, etc.). Freezers lead the market growth. Freezers are the dominant segment driving the growth of the Medical Cold Chain Storage Equipment Market, primarily due to the rising demand for temperature-sensitive pharmaceuticals, biologics, and vaccines. The increasing adoption of ultra-low temperature (ULT) freezers and cryogenic storage solutions has significantly contributed to market expansion. Thermo Fisher, PHC Holdings, Haier Biomedical, and Cryoport are leading the market with technological innovations in ultra-low and cryogenic freezers. The future of medical cold chain storage will continue to be heavily reliant on advanced freezer solutions.

The market is divided into four categories based on Temperature Range: 2°C to 8°C, -20°C to -40°C, -40°C to -80°C and below -80°C. The Medical Cold Chain Storage Equipment Market is categorized based on temperature range to meet different medical storage requirements. Each temperature range serves specific applications and has key players competing in that segment. The Medical Cold Chain Storage Equipment market is segmented by temperature range, with Thermo Fisher, PHC Holdings, and Haier Biomedical leading across multiple categories. Vaccine storage (2°C to 8°C) and mRNA vaccine storage (-80°C and below) are driving demand, while biologics and regenerative medicine are pushing innovations in cryogenic storage.

The market is divided into three categories based on Technology: Compressor-based systems, Absorption-based systems, and Thermoelectric-based systems. The Medical Cold Chain Storage Equipment Market, categorized by technology, plays a crucial role in preserving vaccines, pharmaceuticals, and biologics. The market is segmented into Compressor-based systems, Absorption-based systems, and Thermoelectric-based systems, each with distinct advantages based on application requirements.

The market is divided into four categories based on Application: Vaccine storage, Blood & blood products storage, Biological sample storage, Drug & pharmaceutical storage, and others (organ storage, cell culture media etc.). The Medical Cold Chain Storage Equipment Market, segmented by application, is crucial for preserving temperature-sensitive medical products such as vaccines, blood products, biological samples, and pharmaceuticals. Each application requires specific storage conditions to ensure product integrity and efficacy.

The market is divided into five categories based on End-User: Hospitals & clinics, Pharmaceutical companies, Research laboratories, Blood banks, Pharmacies, and Others (academic institutions, diagnostic centers etc.). Pharmaceutical companies dominate the market growth. The Medical Cold Chain Storage Equipment Market is critical for pharmaceutical companies to ensure the stability and efficacy of temperature-sensitive drugs, vaccines, and biologics. Pharmaceutical companies rely on advanced cold storage technologies to comply with regulatory standards and maintain product integrity during storage and distribution.

Medical Cold Chain Storage Equipment Market- Geographical Insights

North America is at the forefront of market expansion, primarily due to the growth of the biopharmaceutical sector. The United States and Canada host prominent biopharmaceutical companies that are making substantial investments in biologics, monoclonal antibodies, mRNA vaccines, and gene therapies, all of which necessitate rigorous temperature management. As reported by the Pharmaceutical Research and Manufacturers Association (PhRMA), biopharmaceutical companies in the U.S. allocated approximately USD96 billion for research and development in 2023. The Asia-Pacific region is experiencing the fastest growth, propelled by advancements in vaccine production and the expansion of healthcare services. Meanwhile, Europe continues to exhibit robust growth, supported by cutting-edge biotechnology and sustainability efforts.

Medical Cold Chain Storage Equipment Market- Competitive Landscape:

The market for medical cold chain storage equipment is experiencing significant expansion, driven by advancements in technology and the increasing need for temperature-sensitive medications. Organizations that prioritize sustainable and effective cold storage solutions are expected to secure a competitive advantage in this dynamic environment. Major corporations are acquiring smaller firms to broaden their product offerings, as exemplified by Thermo Fisher's acquisition of companies specializing in advanced refrigeration technologies. Additionally, businesses are focusing on the use of environmentally friendly refrigerants and energy-efficient cooling systems to align with global sustainability objectives.

Recent Developments:

On August 8, 2022, Azenta, Inc. announced that it has finalized a definitive agreement to acquire B Medical Systems S.a r.l and its subsidiaries ("B Medical"), which is recognized as a leading provider of temperature-controlled storage and transportation solutions that facilitate the global delivery of life-saving treatments. The total cash purchase price to be disbursed at the time of closing is expected to be around €410 million.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL MEDICAL COLD CHAIN STORAGE EQUIPMENT MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

GLOBAL MEDICAL COLD CHAIN STORAGE EQUIPMENT MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

GLOBAL MEDICAL COLD CHAIN STORAGE EQUIPMENT MARKET, BY TEMPERATURE RANGE- MARKET ANALYSIS, 2019 - 2032

GLOBAL MEDICAL COLD CHAIN STORAGE EQUIPMENT MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032

GLOBAL MEDICAL COLD CHAIN STORAGE EQUIPMENT MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

GLOBAL MEDICAL COLD CHAIN STORAGE EQUIPMENT MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

GLOBAL MEDICAL COLD CHAIN STORAGE EQUIPMENT MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

Table of Contents

1. Medical Cold Chain Storage Equipment Market Overview

2. Executive Summary

3. Medical Cold Chain Storage Equipment Key Market Trends

4. Medical Cold Chain Storage Equipment Industry Study

5. Medical Cold Chain Storage Equipment Market: Impact of Escalating Geopolitical Tensions

6. Medical Cold Chain Storage Equipment Market Landscape

7. Medical Cold Chain Storage Equipment Market - By Product Type

8. Medical Cold Chain Storage Equipment Market - By Temperature Range

9. Medical Cold Chain Storage Equipment Market - By Technology

10. Medical Cold Chain Storage Equipment Market - By Application

11. Medical Cold Chain Storage Equipment Market - By End User

12. Medical Cold Chain Storage Equipment Market- By Geography

13. Key Vendor Analysis- Medical Cold Chain Storage Equipment Industry

14. 360 Degree Analyst View

15. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â